Emil Chuang
CIK: 0001921045
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
PALISADE BIO, INC.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jun 10, 2026PALI
PALISADE BIO, INC.
Award(A)Direct592.3K shares- - Jun 10, 2026PALI
PALISADE BIO, INC.
Exercise(M)Direct20.2K shares- - Oct 6, 2025PALI
PALISADE BIO, INC.
Award(A)DirectRestricted Stock Units
60.6K shares- - Oct 6, 2025PALI
PALISADE BIO, INC.
Award(A)DirectRestricted Stock Units
510.7K shares- - Sep 4, 2025PALI
PALISADE BIO, INC.
Award(A)DirectPhantom Units
18.8K shares- - Jul 18, 2025PALI
PALISADE BIO, INC.
Award(A)DirectStock Option (Right to Buy)
8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 10, 2026 | PALI PALISADE BIO, INC. | Award(A) | 592,300 | - | $0 | Direct |
| Jun 10, 2026 | PALI PALISADE BIO, INC. | Exercise(M) | 20,200 | - | $0 | Direct |
| Oct 6, 2025 | PALI PALISADE BIO, INC. | Award(A) Restricted Stock Units | 60,600 | - | - | Direct |
| Oct 6, 2025 | PALI PALISADE BIO, INC. | Award(A) Restricted Stock Units | 510,700 | - | - | Direct |
| Sep 4, 2025 | PALI PALISADE BIO, INC. | Award(A) Phantom Units | 18,800 | - | - | Direct |
| Jul 18, 2025 | PALI PALISADE BIO, INC. | Award(A) Stock Option (Right to Buy) | 8,000 | - | - | Direct |
1-6 of 6 transactions
About Chuang Emil
Chuang Emil (SEC CIK 0001921045) files insider reports with the SEC as Director of PALISADE BIO, INC. (PALI).
Signal8 holds 6 ownership filings by Chuang Emil (1 Form 3, 5 Form 4), filed between Jul 17, 2025 and Jun 12, 2026. Those filings report 6 transactions, from Jul 18, 2025 to Jun 10, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Chuang Emil's filings is in DENVER, CO.
Recent filings by Chuang Emil
- Jun 10, 2026: Grant or award of PALI shares (Form 4, code A).
- Jun 10, 2026: Option exercise of PALI shares (Form 4, code M).
- Oct 6, 2025: Grants or awards of PALI derivative securities (2 lines, Form 4, code A).
- Sep 4, 2025: Grant or award of PALI derivative securities (Form 4, code A).
- Jul 18, 2025: Grant or award of PALI derivative securities (Form 4, code A).
Other insiders filing for PALISADE BIO, INC. (PALI)
- Capers Julien E.
- Jones Mitchell Lawrence
- Finley John David, CEO CFO
- Williams Donald Allen, Director
- Baltera Robert Jr., Director
- Wei Binxian, Director